Director, Preclinical Immunology & mRNA Therapeutics

Kernal Biologics, Inc.; Boston (MA); On-site; USD 130,000 - 170,000; Full time

Benefits offered by this job

Competitive 401(k)

Highly competitive healthcare coverage

Flexible Spending Account

Paid parental leave

On-site cafeteria

Competitive vacation and sick days

Job summary

A leading therapeutics company in Boston is seeking an Associate Director/Director of Preclinical Development to lead mRNA immunology efforts. The ideal candidate will have a strong background in drug development, excellent communication skills, and 7+ years of Biotech/Pharma experience. You will design and execute preclinical studies while managing collaborations with regulatory agencies. This role offers a dynamic start-up environment and the chance to impact patient care through innovative therapies.

Qualifications

• 7+ years of Biotech/Pharma experience, including 3+ years in managerial roles.
• Comprehensive knowledge of preclinical development in autoimmune diseases.
• Strong passion for innovative research in mRNA therapeutics.

Responsibilities

• Guide preclinical immunology efforts for mRNA therapeutics.
• Design and execute preclinical studies for in vivo CAR-T programs.
• Collaborate with cross-functional teams and oversee timelines and budgets.

Skills

Immunology expertise

Drug development

Excellent communication skills

Hands-on experience with multi-parameter flow cytometry

Collaboration with regulatory agencies

Education

MD or PhD in toxicology, pharmacology, immunology

Tools

qPCR

Western blotting

Job description

A leading therapeutics company in Boston is seeking an Associate Director/Director of Preclinical Development to lead mRNA immunology efforts. The ideal candidate will have a strong background in drug development, excellent communication skills, and 7+ years of Biotech/Pharma experience. You will design and execute preclinical studies while managing collaborations with regulatory agencies. This role offers a dynamic start-up environment and the chance to impact patient care through innovative therapies.